1887

Abstract

SUMMARY: The intracerebral invasion in mice by two ( strains, a virulent strain and the strain 18–323 which is very virulent on intracerebral injection, was studied. The LD50 of these strains differed by about a thousand times and the average slopes of the regression lines from which these were calculated differed significantly, ( = 0·04 and = 0·01). It was found that the number of organisms/mouse brain in infected animals reached a maximum count which was slightly higher for the more virulent strain. The day on which the maximum count was reached depended both on the dose of organisms and the strain used, but occurred always before the seventh day after injection. Further, a slightly lower maximum count was reached as the dose of organisms was decreased. The passive protection by rabbit sera, described as antibacterial and antitoxic sera, against both these strains of pertussis organisms, was studied. It was shown that the protection of neither type of serum was due only to the presence of agglutinin antibodies.

Loading

Article metrics loading...

/content/journal/micro/10.1099/00221287-18-1-48
1958-02-01
2024-11-13
Loading full text...

Full text loading...

/deliver/fulltext/micro/18/1/mic-18-1-48.html?itemId=/content/journal/micro/10.1099/00221287-18-1-48&mimeType=html&fmt=ahah

References

  1. Bliss C. I. 1935; The calculation of the dosage mortality curve. Ann. appl. Biol 22:134
    [Google Scholar]
  2. Brown H. G., Kirwan E. W. O. ’G. 1915; Standardisation of bacterial suspensions by opacity. Indian J. med. Res 2:763
    [Google Scholar]
  3. Burnet F. M., Timmins C. 1937; Experimental infection with Haemophilus pertussis in the mouse by intranasal inoculation. Brit. J. exp. Path 18:83
    [Google Scholar]
  4. Cohen S. M., Wheeler M. W. 1946; Pertussis vaccines produced with phase 1 cultures grown on fluid medium. Amer. J. publ. Hlth 36:371
    [Google Scholar]
  5. Cooper G. N. 1952; Activity immunity in mice following the intranasal injection of sub-lethal doses of living Haemophilus pertussis . J. Path. Bact 64:65
    [Google Scholar]
  6. Evans D. G., Adams M. O. 1952; The inability of the capsular material of Haemophilus pertussis to produce protective antisera. J. gen. Microbiol 7:169
    [Google Scholar]
  7. Evans D. G., Maitland M. B. 1937; The preparation of the toxin of Haemophilus pertussis, its properties and relation to immunity. J. Path. Bact 45:715
    [Google Scholar]
  8. Evans D. G., Perkins F. T. 1954a; The ability of Pertussis vaccine to produce in mice specific immunity of a type not associated with antibody production. Brit. J. exp. Path 35:322
    [Google Scholar]
  9. Evans D. G., Perkins F. T. 1954b; Interference immunity produced by Pertussis vaccine to pertussis infection in mice. Brit. J. exp. Path 35:603
    [Google Scholar]
  10. Evans D. G., Perkins F. T. 1955; The production of both interference and antibody immunity by Pertussis vaccine and pertussis infection in mice. Brit. J. exp. Path 36:391
    [Google Scholar]
  11. Fisher R. A., Yates F. 1949 Statistical Tables for Biological, Agricultural and Medical Research Edinburgh: Oliver and Boyd;
    [Google Scholar]
  12. Fisher S. 1955; Multiplication of Haemophilus pertussis in the mouse lung following intranasal infection. Aust. J. exp. Biol 33:609
    [Google Scholar]
  13. Keppie J., Smith H., Harris-Smith P. W. 1953; The chemical basis of the virulence of Bacillus anthracis. II. Some biological properties of bacterial products. Brit. J. exp. Path 34:486
    [Google Scholar]
  14. Keppie J., Smith H., Stanley J. L. 1953; A method for collecting bacteria and their products from infections in experimental animals, with special reference to Bacillus anthracis . Brit. J. exp. Path 34:471
    [Google Scholar]
  15. Kendrick P. L., Eldering G., Dixon M. K., Misner J. 1947; Mouse protection tests in the study of Pertussis vaccine. A comparative series using the intracerebral route for challenge. Amer. J. publ. Hlth 37:803
    [Google Scholar]
  16. Kendrick P. L., Updyke E. L., Eldering G. 1949; Comparison of pertussis cultures by mouse protection and virulence tests. Amer. J. publ. Hlth 39:179
    [Google Scholar]
  17. Linggood F. Y., Fenton E. L. 1947; The production of diphtheria toxin by submerged culture in shaking flasks. Brit. J. exp. Path 28:354
    [Google Scholar]
  18. Masry F. L. G. 1952; Production, extraction and purification of the haemagglutinin of Haemophilus pertussis. J. gen. Microbiol 7:201
    [Google Scholar]
  19. Miles A. A., Misra S. S. 1938; The estimation of the bactericidal power of blood. J. Hyg., Camb 38:732
    [Google Scholar]
  20. M.R.C. REPORT 1956; Vaccination against whooping cough. A report to the whooping cough immunisation committee of the Medical Research Council and to the Medical Officers of Health for Leeds, Leyton, Manchester, Middlesex, Oxford, Poole, Tottenham, Walthamstow and Wembley. Brit. med. J ii454
    [Google Scholar]
  21. Norton J. F., Dingle J. H. 1935; Virulence tests for typhoid bacilli and antibody relationships in antityphoid sera. Amer. J. publ. Hlth 37:803
    [Google Scholar]
  22. Ospeck A. G., Roberts M. E. 1944; Pertussis antitoxin: its relationship and protection in actively and passively immunised mice and rabbits. J. infect. Dis 74:22
    [Google Scholar]
  23. Pillemer L. 1950; Adsorption of protective antigen of Haemophilus pertussis on human red cell stromata. Proc. Soc. exp. Biol., N.Y 75:704
    [Google Scholar]
  24. Pillemer L., Blum L., Lepow P. H. 1954; Protective antigen of Haemophilus pertussis . Lancet i:1257
    [Google Scholar]
  25. Proom H. 1947; The immunological aspects of Haemophilus pertussis infection. J. Path. Bact 59:165
    [Google Scholar]
  26. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent end points. Amer. J. Hyg 27:493
    [Google Scholar]
  27. Roberts M. E., Ospeck A. G. 1944; A pertussis toxin-antitoxin neutralisation technique. J. infect. Dis 74:14
    [Google Scholar]
/content/journal/micro/10.1099/00221287-18-1-48
Loading
/content/journal/micro/10.1099/00221287-18-1-48
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error